Lymphocyte recruitment maintains intestinal immune homeostasis but also contributes to inflammation. The orphan chemoattractant receptor GPR15 mediates regulatory T cell homing and immunosuppression in the mouse colon. We show that GPR15 is also expressed by mouse T H 17 and T H 1 effector cells and is required for colitis in a model that depends on the trafficking of these cells to the colon. In humans GPR15 is expressed by effector cells, including pathogenic T H 2 cells in ulcerative colitis, but is expressed poorly or not at all by colon regulatory T (T reg ) cells. The T H 2 transcriptional activator GATA-3 and the T reg -associated transcriptional repressor FOXP3 robustly bind human, but not mouse, GPR15 enhancer sequences, correlating with receptor expression. Our results highlight species differences in GPR15 regulation and suggest it as a potential therapeutic target for colitis.
Recruitment of lymphocytes from the circulation is a tissue-and cellspecific process that is mediated by adhesion and chemoattractant receptors 1, 2 . The interaction of lymphocyte adhesion receptors with their ligands on vascular endothelium allows endothelial capture of blood-borne lymphocytes and mediates lymphocyte rolling, but arrest and firm adhesion of rolling cells, as well as subsequent diapedesis, require the engagement of lymphocyte receptors of the chemoattractant GPCR family 3 . Signaling via these chemoattractant receptors triggers rapid integrin-dependent lymphocyte adhesion on the endothelium and activates and drives programs of lymphocyte motility. Chemoattractant receptors thus play critical roles in the recruitment of lymphocyte subsets from the blood, and they direct the trafficking of lymphocyte subsets in both homeostatic and inflammatory states 3, 4 . As examples, CCR7 helps target naive lymphocytes and subsets of memory and effector cells to lymph nodes and tertiary lymphoid tissues in chronic inflammation; CCR10, CCR8 and CCR4 participate selectively, though not exclusively, in skin homing by memory and effector T cells; and CCR9 serves as a specific T cell and plasmablast homing receptor for the small intestines 5 . Interestingly, CCR10 also targets IgA plasmablast homing to mucosal tissues, including the bronchial tree and the colon, but it is not expressed by gut-homing T cells: CCR10 expression on T cells is largely mutually exclusive with that of the integrin intestinal homing receptor α 4 β 7 (ref. 5) , which is required for efficient lymphocyte homing to the intestines through its recognition of the mucosal vascular addressin MAdCAM1 (refs. 3,6) . Although inflammatory chemokines and their receptors may participate in homing 7, 8 , whether colon effector and memory T cells have specific chemoattractant trafficking receptors analogous to skin and small intestinal T cell-selective chemokine receptors has remained unclear.
GPR15 is an 'orphan' GPCR and an HIV co-receptor that is structurally related to known lymphocyte trafficking receptors 9, 10 . A recent study has implicated this receptor in colon homing of T reg cells in the mouse 11 , but its role in effector T cell trafficking and function is not known. Here we examine the expression and function of GPR15 on effector T cells in mouse and man. Our results show that GPR15 is important for effector as well as regulatory T cell localization to the mouse colon and implicate GPR15-dependent effector cell recruitment in mouse colitis. We also describe substantial differences in GPR15 expression in the human, with expression by T H 2 cells but not T reg cells in the normal and inflamed human colon. We relate the expression of GPR15 by human T H 2 cells and by mouse, but not human, T reg cells to interspecies differences in binding of transcriptional regulators to Gpr15 enhancer sequences.
RESULTS

Activated colon CD4 + T cells express GPR15
Using Gpr15-GFP knock-in mice 11 , we confirmed that GFP + CD4 + cells are most frequent among T cells in colon lamina propria (LP) as compared to small intestine (SI) and peripheral lymphoid 2 0 8 VOLUME 16 NUMBER 2 FEBRUARY 2015 nature immunology A r t i c l e s Figure 1 GPR15 mediates accumulation of T EM and T reg cells in the colon. (a) Ratios of Gpr15-KO-to Gpr15-het-derived cells (CD45.2/CD45.1) among T reg cells (CD4 + , CD25 hi , Foxp3 + ; top), T reg -excluded T EM cells (CD4 + , Foxp3 − , CD44 hi , CD45RB lo ; middle), and naive CD4 + T cells (CD4 + , Foxp3 − , CD44 lo , CD45RB hi ; bottom) in Exp mixed bone marrow chimeras (white bars), and ratios of Gpr15-het to het cells (CD45.2/CD45.1) in control chimeras (black bars). Chimeras were generated by combining Gpr15-KO (CD45.2) or Gpr15-het (CD45.2) bone marrow cells with Gpr15-het (CD45.1) cells and transferring them into irradiated hosts (CD45.1 × CD45.2 F 1 ) to generate experimental (Exp) or control (Ctrl) chimeras, respectively, as in Supplementary  Figure 2a . PLN, peripheral lymph nodes; MLN, mesenteric lymph node; PP, Peyer's patches; SI, small intestine. n = 3 for each condition; mean ± s.e.m., **P < 0.01 (two-way ANOVA, Bonferroni post-test). Representative of three experiments. (b) Balb/c (Thy-1.1) mice that received DO11.10 Gpr15-het or DO11.10 Gpr15-KO splenocytes, and treatment with OVA and CT, were assessed 5 d later, as in Supplementary Figure 2c . The percentage of antigen-specific (DO11 + ) cells among Gpr15-het or Gpr15-KO CD4 + T EM cells (CD44 hi , CD45RB lo ) 5 d after antigen exposure was normalized to the ratio in the spleen. Data from 9 mice from three independent experiments are shown. Mean ± s.e.m., *P < 0.05 (two-way ANOVA, Bonferroni post-test). (c) Balb/c (Thy-1.1) mice received CFSE-labeled splenocytes from Gpr15-het (Thy-1.1, Thy-1.2) and KO (Thy-1.2) DO11 mice on day 0, OVA and CT per rectum on day 1, FTY720 or PBS i.p. on day 3, and tissues were collected on day 5, as in Supplementary Figure 2e . (d) Recipient MLN gated on donor DO11 + CD4 + T cells. n = 3 for each condition; mean ± s.e.m. NS, not significant. tissues. They were infrequent among the intraepithelial lymphocytes of the colon or SI, and absent in naive CD4 + T cells of all tissues ( Supplementary Fig. 1a ; ref. 11). GFP + CD4 + T cells in the colon display an activated phenotype, characterized by high expression of activation antigens CD44, CD69 and CD25 and low expression of CD45RB and CD62L ( Supplementary Fig. 1b) ; and they express the integrin homing receptor α 4 β 7 for intestinal vascular adhesion ligand MAdCAM1, but lack the SI trafficking receptor CCR9 ( Supplementary Fig. 1b ). Consistent with a prior report 11 , under homeostatic conditions most, although not all, colon LP GFP + CD4 + T cells express markers of T reg differentiation, including Foxp3, CD25, GITR and Helios, and lack effector cytokine expression ( Supplementary Fig. 1c ).
Gpr15 mediates CD4 + T EM accumulation in the colon
To assess the importance of GPR15 to effector-memory T cells (T EM ) in different tissues, we reconstituted irradiated mice with a mixture of allotype-marked Gpr15 gfp/gfp (Gpr15-knockout; KO) and Gpr15 gfp/+ (Gpr15-heterozygous; het) bone marrow cells, allowing Gpr15-KO and Gpr15-het lymphocytes to compete for niches within a common host environment. Gpr15-KO CD4 + T cells repopulated the colon LP with significantly lower efficiency than their Gpr15-het counterparts ( Supplementary Fig. 2a,b and Fig. 1a ). In contrast, GPR15 deficiency had no effect on the reconstitution of CD4 + T cells in lymphoid tissues or SI LP; nor did it alter colon naive CD4 + T cell frequency ( Fig. 1a) . Notably, accumulation of T EM (CD45RB lo , CD44 hi , Foxp3 − ) cells was reduced to the same extent as that of T reg cells (CD25 high , Foxp3 + ; Fig. 1a ). This accumulation is likely to be mediated by GPR15dependent recruitment because GPR15 effects colon homing of in vitro-generated T EM (Supplementary Fig. 3 ), T reg cells and transduced T cells 11 ; however, effects of GPR15 on retention, survival or proliferation cannot be excluded. These results demonstrate an important role for GPR15 in long-term T EM as well as in T reg reconstitution and homeostasis in the mouse colon.
We next evaluated GPR15 involvement in the generation of colon antigen-specific CD4 + T cells. We transferred allotype-marked, ovalbumin-specific (DO11.10) Gpr15-KO or Gpr15-het splenic CD4 + T cells into recipient mice that were immunized intrarectally 24 h later with ovalbumin and cholera toxin ( Supplementary Fig. 2c ), a procedure that selectively induces T effector cell responses 12 . Activated T cells arising in the colon or draining mesenteric lymph node (MLN) then home via the blood to the colon 13 . Ovalbuminspecific Gpr15-het T cells were more efficient than their Gpr15-KO counterparts at populating the recipient mouse colons ( Fig. 1b and Supplementary Fig. 2d ). This difference was not due to differences in the overall ovalbumin response between the het and KO T cells, as indicated by similar antigen-specific proliferation in the MLN of FTY720-treated mice 14 , in which lymphocyte exit from lymph nodes (MLN) is controlled ( Supplementary Fig. 2e and Fig. 1c,d) . Thus GPR15 supports the accumulation of antigen-reactive CD4 + effector T cells in the colon.
Gpr15 required for CD45RB hi T cell transfer colitis Having shown that GPR15 contributes to colon effector T cell recruitment and accumulation, we next assessed its importance in colon inflammation. We used a well-established model of colitis, the CD45RB hi CD4 + T cell transfer model 15 , in which colitis is dependent on effector T cell expression of intestinal trafficking receptors 16, 17 . In the absence of T reg cells, transferred T cells develop into pathogenic effector T cells that home to the colon and induce disease 15 . Rag2 −/− mice that received naive Gpr15-KO T cells were protected from developing colitis ( Fig. 2) , consistent with a critical function 
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Gpr15-het Gpr15-KO npg for GPR15 on pathogenic effector T cell colon trafficking. Inhibition of colitis by T reg cells in this model does not require colon homing 18 , and accordingly, GPR15-deficient T reg cells and WT T reg cells prevented or delayed colitis in a comparable manner ( Fig. 2) . In the acute DSS-induced model of colitis, in which innate immunity plays a predominant role and colitis is not dependent on T cell colon homing 19, 20 , as well as in the acute TNBS model, Gpr15-KO and WT mice were similarly susceptible to intestinal inflammation ( Supplementary  Fig. 4 ). The inefficiency of Gpr15-deficient cells in inducing colitis in the CD45RB hi transfer model thus reveals a role of GPR15 in the colon trafficking of pathogenic proinflammatory T cells. Colitis in the naive T cell transfer model depends on the generation of pathogenic IFN-γ-and IL17-producing T H 1 and T H 17 effector CD4 + cells [21] [22] [23] . To determine whether a deficiency in generation or localization of such effector cells might underlie or contribute to the reduced ability of KO T cells to induce colitis, we transferred allotypemarked naive Gpr15-KO and Gpr15-het CD4 + T cells together into Rag2 −/− mice and assessed the presence of effector T cells in recipient tissues 2 weeks later, before the clinical onset of colitis ( Supplementary Fig. 5a ). Compared to GFP + Gpr15-KO T cells, GFP + Gpr15-het (GPR15-expressing) T cells preferentially accumulated in the colons of Rag2 −/− recipients, consistent with a prominent role for GPR15 in effector T cell localization ( Fig. 3a) . On the other hand, GPR15 deficiency had no significant effect on the frequency of T H 1 and T H 17 effector T cells among the donor populations ( Fig. 3b and Supplementary Fig. 5b-d) ; on the fraction of proliferating T cells, as indicated by the extent of BrdU incorporation ( Fig. 3c) ; or on that of apoptotic CD4 + T cells, as indicated by annexin V staining (data not shown). In related Rag2 −/− transfer studies ( Supplementary  Fig. 5e ), we found that GFP-expressing subsets of colon-localized Gpr15-KO-and Gpr15-het-derived cells also displayed similar expression of cytokines, Foxp3 and Ki67 (Supplementary Fig. 5f ). These data suggest that the failure of GPR15-deficient T cells to induce colitis is not due to alterations in T cell activation or production of proinflammatory cytokines.
GPR15 expression on human CD4 + T cells
To determine the relevance of these mouse studies to humans, we assessed GPR15 expression by colon CD4 + T cells from individuals with ulcerative colitis (UC; a 'T H 2-like' disease in which inflammation is limited to the colon 24 ) or Crohn's disease (typically a T H 1 and T H 17 disease 25 ) and in colons from individuals without UC that included healthy or normal margins of cecal or colorectal adenocarcinomas. Unexpectedly, GPR15 was highly enriched among UC colon T H 2 cells (IL-5 + or IL-13 + ; Fig. 4a ). Few IFN-γ + or IL-17 + effector T cells expressed the receptor ( Fig. 4a ) and, in contrast to the npg A r t i c l e s data from mice, there was little or no GPR15 expression on T reg cells (CD127 lo , Foxp3 + , CD4 + ) from either UC or non-UC colons ( Fig. 4 and Supplementary Fig. 6 ). T reg cells lacked GPR15 expression whether resting or activated (Supplementary Fig. 6b ). Consistent with this differential expression in vivo, GPR15 is preferentially induced on in vitro-generated human T H 2 effector cells (IL-4 + ), but not on T reg cells under conventional polarizing conditions ( Fig. 5a ; Foxp3 + cells are CD127 lo ; not shown). In contrast, GPR15 expression was observed in mouse cells under T reg and T H 17 cells ( Fig. 5b ; and see ref. 11 ), but not T H 2-polarizing conditions (Fig. 5b) .
These results highlight GPR15 expression by pathogenic T cells in colitis and reveal dramatic differences in the patterns of cell type GPR15 expression in humans as compared to mice.
Binding of GATA-3 to GPR15 enhancer region GATA-3 is the master regulator of T H 2 cell differentiation and cytokine expression 26 , and it interacts with Foxp3 to regulate gene expression in T reg cells [27] [28] [29] . In an attempt to identify mechanisms underlying T-cell-subset-and species-specific GPR15 regulation, we analyzed GATA-3 binding at the human and mouse loci using previously generated ChIP-Seq data 30, 31 (Fig. 6a,b) . We found that GATA-3 bound to a highly conserved site downstream of GPR15 in humans, but not in mice (site marked "Downstream" in Fig. 6a,b) . In contrast, GATA-3 bound to a site upstream of GPR15 close to CLDND1 in humans and Cldn25 in mice (marked "Upstream" in Fig. 6a,b) . The significance of these interactions was confirmed using model-based analysis of ChIP-Seq (MACS), which identifies significant numbers of sequence reads indicative of transcription factor binding sites 32 . MACS identifies both the upstream and downstream GATA-3 binding sites in humans, with P values of 2.6 × 10 −101 and 1.1 × 10 −63 , respectively (83 and 111 sequence reads, respectively), but only the upstream Cldn25-and CLDNDI-associated site was significant in mouse (P = 6 × 10 −37 with 80 reads compared to only 9 reads for the downstream site, determined as not significant by MACS). A GATA-3 binding site within the IL4 CNS2 was identified as significant in both human and mouse (1. npg was confirmed by ChIP-qPCR, with binding to the upstream site and to the IL4 CNS2 element remaining constant between human and mouse (Fig. 6c) . Consistent with this species-specific binding, consensus GATA-3 sites could be identified at this site in human but not in mouse (Supplementary Fig. 7) . Notably, a tandem GATA-3-STAT-6 motif is conserved in multiple species, but it contains an A-to-G nucleotide difference in the mouse (Supplementary Fig. 7) , a mutation known to attenuate GATA-3 binding 33 (T.T.D. and J.P., unpublished data).
Histone marks indicative of active chromatin characterize this region in the GPR15-expressing ENCODE cell line GM12878 (Supplementary Fig. 7) , whereas repressive chromatin modifications are observed in cell lines that do not express GPR15. We therefore hypothesized that the downstream site is an enhancer that is active in human T H 2 cells. To test this, we performed ChIP-Seq for the active enhancer mark H3K27ac and the transcriptional initiation mark H3K4me3 in in vitro-polarized human T H 1 and T H 2 cells (Fig. 6a) . We found that the site was indeed associated with H3K27ac, and more so in T H 2 than in T H 1 cells, mirroring the expression of GPR15. The upstream site and the GPR15 gene were also associated with greater abundance of the H3K4me3 mark in T H 2 cells. In contrast, no H3K4me3 is present at the downstream site or at the GPR15 gene in mouse (Fig. 6b) , consistent with the lack of GATA-3 binding. We conclude that GATA-3 exhibits differential binding to an enhancer at the GPR15 locus between human and mouse and that this contributes to the differing patterns of enhancer activation and GPR15 expression in T H 2 cells between the two species.
Foxp3 is responsible for the repression of T effector genes in T reg cells 34 . We therefore considered that differential binding of this factor could be responsible for the differential expression of GPR15 between mouse and human T reg cells. ChIP-Seq for FOXP3 in human and mouse T reg cells identified significant binding to the GPR15 enhancer in human but not mouse (Supplementary Fig. 8) . In human T reg cells, the GPR15 enhancer was one of the most significant binding sites, having P values between 1.7 × 10 −11 and 1.7 × 10 −80 and being in the top 1% of sites in four different experiments. By contrast, in replicate experiments in mouse, the P values for Foxp3 binding to the Gpr15 enhancer were 1.4 × 10 −4 and 2.6 × 10 −4 , below the default MACS significance threshold of 10 −5 and only within the top 13% or 23%, respectively, of all sites with P < 10 −3 . Therefore, the low expression of GPR15 in human T reg cells may reflect efficient binding and repression by FOXP3.
DISCUSSION
GPR15 is an HIV co-receptor and an orphan GPCR with structural homology to known chemokine receptors. Recently, GPR15 was shown to be expressed by colon T reg cells and to contribute to their homing to, and function in, the colon. Our studies reveal that GPR15 is also an effector-memory CD4 + T cell receptor with a role in CD4 + T EM cell homing and colitis pathogenesis, whose expression is differentially regulated in CD4 + T cell subsets between humans and mice. We show that GPR15 expression is enriched on human T H 2 colon cells, but in striking contrast to the data from mouse, most human colon T reg cells (whether in colons from individuals with or without inflammatory bowel disease) fail to express GPR15. We identified mutations that disrupt GATA-3 binding and GPR15 enhancer activation in the mouse enhancer region, and described differences in GATA-3 and FOXP3 binding to the enhancer in mice versus humans that may underlie the species-specific regulation of GPR15 on effector versus regulatory T cell subsets. Moreover, ChIP-Seq data indicate that FOXP3, a repressor of T H 2-associated genes in T reg cells, binds with high efficiency to the human but not mouse enhancer in T reg cells, correlating with inhibition of GPR15 expression in human regulatory T cells.
Our results are consistent with, but extend, those of another study 11 . The study's authors used transfected naive lymphocytes to show convincingly that GPR15 functions as a colon homing receptor, and they demonstrated its role in T reg cell localization and function in the colon as well. Our results confirm the receptor's role in T reg cell localization in the mouse, but they also demonstrate a similarly A r t i c l e s important role in T EM cell homing and accumulation in the large intestine. Although GPR15's action as a T cell trafficking receptor for the colon is now established, additional roles for the receptor in cell retention or survival are not ruled out, nor is its involvement in homing to other epithelial surfaces 35 . Expression of GPR15 on T reg cells was previously shown to be required for transferred T reg cells to prevent mortality and severe colitis associated with Citrobacter rodentium 11 , a widely accepted model of infectious colitis with properties similar to the colitis caused by human pathogen enteropathogenic Escherichia coli. We, however, employed the widely used CD45RB hi CD4 + T cell transfer colitis model that does not require T reg cell homing to the colon for disease control. T reg cell suppression of colitis in the CD45RB hi CD4 + T model does not appear to require gut homing: T reg cells deficient in integrin β 7 are fully capable of suppressing disease 18 , whereas T reg cell suppression of colitis in this model requires T reg cell migration to lymph nodes; CCR7-deficient T reg cells were less efficient at preventing colitis than were CCR7-sufficient T reg cells 36 . In contrast, the pathogenic T cells in the CD45RB hi CD4 + T cell transfer model do require intestinal trafficking receptors for colitogenesis: colitis in this model is inhibited by antibody blockade of the gut homing receptor α 4 β 7 or by genetic deficiency of integrin β 7 (refs. 17,37) ; and we showed that it is also inhibited by GPR15 deficiency on transferred T cells. β 7 integrin deficiency does not alter the course of DSS-induced colitis 19, 20 , correlating with the lack of effect of GPR15 deficiency, and likely owing to the noncritical role of T cells in the acute chemically induced models of colitis. Together, the results highlight the importance of GPR15 expression for T cell localization and function in the colon. GPR15-dependent T cell homing can mediate immune pathogenesis in T effector-cell driven colitis when T EM cell activity is required locally in the colon, but it can contribute to immune regulation in models in which T reg cell responses are important locally in the gut wall. In this context, we note that the CD45RB hi CD4 + T cell transfer model has been used to identify and validate antibody inhibitors of intestinal lymphocyte trafficking that have led to effective therapeutics for human colitis 17, 38, 39 . These considerations may have significant implications for the translation of mouse studies to the human. Our data show that patterns of GPR15 expression are quite different in man. In sharp contrast to the mouse, in humans few if any colon T reg cells isolated from individuals with colon cancer (normal adjacent tissue), ulcerative colitis or Crohn's disease expressed the receptor. The highest frequency of GPR15 expression was found on T H 2 effector T cells, an important population of pathogenic T EM cells in the colon of ulcerative colitis patients 24, 40, 41 . Notably, in vitro-generated human, but not mouse, T H 2 cells expressed GPR15. Although it is not feasible to carry out functional studies of the orphan receptor in humans, GPR15 is highly conserved in mammalian species including man. Thus our results suggest that GPR15 may help target pathogenic T H 2 cells to the colon in humans but is probably less important in humans than in mice for the homing and function of regulatory T cells in the gut wall.
We identified an active GPR15 enhancer region with marked differences in sequence and cell-type-specific transcription factor binding and chromatin marks in human and mouse. The human enhancer comprises canonical GATA-3 binding motifs that are conserved in multiple species but missing in the mouse. GATA-3 plays key roles in T H 2 cell differentiation and cytokine expression 26 . GATA-3 ChIP-Seq data 30, 31 and targeted ChIP-qPCR revealed that GATA-3 binds to the 3′ (downstream) GPR15 enhancer in human but not mouse T H 2 cells, whereas binding to a site upstream at human CLDND1 and mouse Cldn25 and to the established IL4 CNS2 locus is conserved between the two species. The active enhancer mark H3K27ac and the transcriptional initiation mark H3K4me3 in human T H 1 and T H 2 cells confirmed the increased activity of the enhancer and increased expression of GPR15 in human T H 2 cells. Unlike in the human, H3K4me3 is not observed at Gpr15 or its enhancer in mouse T H 2 cells. We conclude from these experiments that GATA-3 only binds, and the enhancer is only activated, in human T H 2 cells and not in mouse T H 2 cells.
We also found that Gpr15 expression in T reg cells is species specific, being suppressed in human cells. Potentially explaining this, ChIP-Seq for Foxp3, a transcriptional regulator necessary for repression of T effector cell genes in T reg cells 42, 43 , demonstrates significant binding to the GPR15 enhancer only in human and not mouse T reg cells. Foxp3 is thought to bind DNA with cofactors, including GATA-3 (ref. 29) , and thus the reduced binding of Foxp3 to the Gpr15 enhancer in mouse T reg cells may be due to differences in GATA motifs and loss of GATA-3 binding. Additional factors are also likely to be involved in the differential expression of GPR15 between human and mouse T cell subsets, including those responsible for the increased expression in mouse T H 17 cells.
Although differences in transcription factor binding between species have been reported 44 , to our knowledge, the differential binding of GATA-3 at GPR15 between human and mouse is the first example in which defined differences in transcription factor binding have been associated with species differences in targeting mechanisms of functionally distinct T cell populations, differences expected to result in altered patterns of local (T H cell-derived) cytokine production and thus mechanisms of pathogenesis. Manipulation of the enhancer sequences in T cells in vitro and in vivo will be required to elucidate the specific consequences of the species differences in GATA-3 binding shown here.
In conclusion, our studies show that GPR15 can control the colon localization of T effector cells, and we demonstrate its key role in a model of colitis that requires effector cell homing to and function in the gut wall. Our studies also identify significant differences in T reg as compared to T effector cell expression of the receptor between mice and humans, differences that suggest a predominant proinflammatory role for GPR15 in man. These species differences may fundamentally restrict the relevance of mouse models for the study of T reg trafficking in colitis. Indeed, given its preferential expression by pathogenic effector cells in man, inhibition of GPR15 may present a therapeutic approach to controlling inflammatory T cell recruitment in ulcerative colitis.
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